Nutra Pharma Corp (NPHC)

[fly_fisherman]

SUMMARY - What this company is all about:(updated)




Incredible interview putting all the chips on the table:

------------------------------------------------------

MOST RECENT UPDATES:

Purdue Approaches States in Bid to Settle Opioid Claims

November 17, 2017


The Lawyer Who Beat Big Tobacco Takes On the Opioid Industry


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136295516

------------------------------------------------------

Opioid abuse crisis takes heavy toll on US Veterans ...


November 10, 2017

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136383808

=============================

Its my understanding Rik has consultants already working with the various state, federal, and health industry decision makers to

introduce Nyloxin and share the results and its viability as an alternative to opioid's.

Rik had mentioned in his email stickied above that they are working with the government and VA. I can't help but think some of the

joint ventures he also discussed could include not only the FDA Orphan Drug Status Phase II trials but also getting Nyloxin out

there as an alternative to opioid's.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136051474

=============================


Share Structure:
Date: 12-11-17
A/S: 2 billions
O/S: Beginning today 1,999,996,261.We think it is close to maxing out.
Restricted Shares: 152,623,316

Float at most: 1.85 billion shares



Excellent observation Cache....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134731789

Well, let's see... OWC* ran to over $300M market cap on possible orphan drug status with no clinical trials, product, or

revs at the time. We already have a celebrity endorsement on one of our existing products and awaiting Phase II study news, so....

300 Million and not near the potential as NPHC!

We sit at 1.3 million market cap now. Laughable. Not for long!!!

Its all in the market cap folks!!!

Just for Grins 300 million would represent a PPS of .16 cents for NPHC.

NPHC IS NO ONE TRICK PONY!!!

CATALYSTS:

1) PEDIATRIC MS(RPI-78M), AMN, MG, ALS
* ORPHAN DRUG STATUS
https://finance.yahoo.com/news/nutra-pharmas-rpi-78m-granted-123000069.html
* FDA Trials Phase II soon
* Addresses multiple health conditions
  http://www.receptopharm.com/drug_development/
* RPI-78M is being developed for the treatment of Multiple Sclerosis (MS) and Adrenomyeloneuropathy

(AMN).Other neurological disorders    that may be served by RPI-78M include Myasthenia Gravis (MG) and

Amyotrophic Lateral Sclerosis (ALS)
* Collaboration: University of Maryland,production of RPI-78M for the planned upcoming clinical trials in Pediatric Multiple

Sclerosis
  https://finance.yahoo.com/news/nutra-pharma-announces-collaboration-university-123000318.html


2) NYLOXIN Non addictive pain solutions - OPIOID Alternative (FDA Registered)
* Amazon today
* Soon to be in retail
  https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136051474
* Ongoing efforts to get our products into the VA and government buyers(Rik)-Article below shows VA need today!
  https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136051474
   Opioid abuse crisis takes heavy toll on US Veterans ...
   November 10, 2017
   President Donald Trump named opioids a national public health emergency and a White House commission last

week recommended    establishing a nationwide system of drug courts and easier access to

alternatives to opioids for people in pain.
   http://www.foxnews.com/health/2017/11/10/opioid-abuse-crisis-takes-heavy-toll-on-us-veterans.htm
* https://nyloxin.com/
* “All the principle work has been in humans. So, the Nyloxin product is amazing. It’s non-addictive, no opiate,

non-narcotic. In the last model, it outperformed morphine. It lasted six hours longer than morphine without any of

the side effects,” explained Rik Deitsch, CEO of Nutra Pharma Corp.
https://www.nbcmiami.com/news/local/South-Florida-Company-Turns-Cobra-Venom-Into-Healing-Treatment-413791863.html
* Supported by Jack Brewer. Non addictive pain solutions!!!! Retweeted!!!!
 Jack Brewer @JackBrewerBSI Oct 2
 I don’t know what I would do without my @nyloxin!! Keeps me going
 Jack Brewer is the Executive Chairman & Portfolio Manager of The Brewer Group.
 Very successful investor/financier and has connections with Bio Tech!!! Visits Fox Business frequently!

3) PET PAIN AWAY - For animals pain and suffering - Non addictive pain solutions
* ongoing infomercial campaign for Pet Pain-Away (Rik)
* Pet Pain Away added to vetrinarial student text
http://www.otcmarkets.com/stock/NPHC/news/New-Edition-of-Textbook-on-Treating-Canine-Arthritis-Includes-Nutra-Pharma-Pain-Remedy?id

=166273&b=y

4) Pink Sheet "CURRENT" (Audited).
* U.S. Reporting: SEC Reporting "Current" - Folks we are NOT some deregistered non-audited holding. We are fully SEC reporting.
* Audited means everything to me, many pinkies aren't.
* SOS Active and Current
* Recently a "QB" stock dropped to pinky some months ago when we dipped below a penny.
* When we bust into pennies again we will get back to "QB" quickly.
http://www.otcmarkets.com/stock/NPHC/profile

5) 10 Drugs in the Pipeline
http://www.receptopharm.com/drug_development/pipeline.php

6) Financing with Legitimate Lenders (2 - 20 MILLION)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136051474

7) Joint Ventures on the Way
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136051474

8) 21 Patents

9) 400,000 debt reduced!
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12359349

10) Undervalued (NOT FOR LONG) because of toxic's that are close to being if not already completed!

11) Vastly Undervalued compared to other Bio's and Pharma with less in their pipelines.

12) No planned R/S in near future.

13) Email from Rik (Great things on the horizon)
CEO UPDATE: NPHC
We need to file our 10Q next week. After that, we can announce our ‘go-forward’ plans for the company. This includes: the ongoing

infomercial campaign for Pet Pain-Away; the marketing of Nyloxin; the retail rollout for Nyloxin; the ongoing efforts

to get our products into the VA and government buyers; our efforts in International registrations for our products; and

our efforts in moving RPI-78M into clinical trials for Pediatric Multiple Sclerosis under our Orphan Designation. We are working

with finance partners and potential joint venture partners to bring in from $2M to $20M in furtherance of the business plan. We

expect to make announcements later this month to update our shareholders.

Thank you for your interest in Nutra Pharma,

Rik

Post from (tink):
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136038708

Screenshot (Cache):
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136051474

* What I noticed about this email. No reference of toxic's still in play. Normally correspondence with Rik would reflect the
toxic's still being an issue. We will see.


REVIEW:

What irons are in the fire we do not know about? The items we have so far can be verified by 10Q's, websites, snapshots of

emails, etc. I am sure I have missed something. There are so many opportunities here. A few have brought up the issue of debt.

Folks this is OTC/pinky land. What stock doesn't have debt. Rik has already mentioned joint ventures. I believe Rik and others are

working out financing agreements with legitimate lenders which will enable NPHC to bring to market new and existing groundbreaking

and much needed solutions! The positives far out way the negatives and WE ARE AT THE GROUND FLOOR! Trips are

about as low as you can get folks! Just how many sub penny stocks have a portfolio of products and potential that NPHC currently

has? Then look at our current Market Cap. Enough said IMHO! There are never any guarantees in the land of pinky's but I like our

chances. The list above is filled with a multitude of material events all capable of driving up the Market Cap/PPS in quick

fashion. Like I have said before perform your own DD and see what you find.